Logo image of BCO.DE

BOEING CO/THE (BCO.DE) Stock Fundamental Analysis

FRA:BCO - Deutsche Boerse Ag - US0970231058 - Common Stock - Currency: EUR

193.32  -1.34 (-0.69%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BCO. BCO was compared to 46 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of BCO have multiple concerns. While showing a medium growth rate, BCO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BCO has reported negative net income.
BCO had a negative operating cash flow in the past year.
In the past 5 years BCO always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: BCO reported negative operating cash flow in multiple years.
BCO.DE Yearly Net Income VS EBIT VS OCF VS FCFBCO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -7.04%, BCO is doing worse than 84.78% of the companies in the same industry.
Industry RankSector Rank
ROA -7.04%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCO.DE Yearly ROA, ROE, ROICBCO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

BCO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCO.DE Yearly Profit, Operating, Gross MarginsBCO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BCO has been increased compared to 1 year ago.
The number of shares outstanding for BCO has been increased compared to 5 years ago.
BCO has a better debt/assets ratio than last year.
BCO.DE Yearly Shares OutstandingBCO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BCO.DE Yearly Total Debt VS Total AssetsBCO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

BCO has an Altman-Z score of 1.25. This is a bad value and indicates that BCO is not financially healthy and even has some risk of bankruptcy.
BCO has a Altman-Z score of 1.25. This is amonst the worse of the industry: BCO underperforms 84.78% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.25
ROIC/WACCN/A
WACC9.16%
BCO.DE Yearly LT Debt VS Equity VS FCFBCO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

BCO has a Current Ratio of 1.23. This is a normal value and indicates that BCO is financially healthy and should not expect problems in meeting its short term obligations.
BCO has a Current ratio of 1.23. This is in the better half of the industry: BCO outperforms 60.87% of its industry peers.
A Quick Ratio of 0.38 indicates that BCO may have some problems paying its short term obligations.
The Quick ratio of BCO (0.38) is worse than 89.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.38
BCO.DE Yearly Current Assets VS Current LiabilitesBCO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BCO have decreased strongly by -132.86% in the last year.
Looking at the last year, BCO shows a small growth in Revenue. The Revenue has grown by 2.41% in the last year.
The Revenue has been decreasing by -4.74% on average over the past years.
EPS 1Y (TTM)-132.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.24%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%34.88%

3.2 Future

Based on estimates for the next years, BCO will show a very strong growth in Earnings Per Share. The EPS will grow by 21.08% on average per year.
Based on estimates for the next years, BCO will show a quite strong growth in Revenue. The Revenue will grow by 14.49% on average per year.
EPS Next Y91.1%
EPS Next 2Y47.72%
EPS Next 3Y32.64%
EPS Next 5Y21.08%
Revenue Next Year26.24%
Revenue Next 2Y20.59%
Revenue Next 3Y17.28%
Revenue Next 5Y14.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BCO.DE Yearly Revenue VS EstimatesBCO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
BCO.DE Yearly EPS VS EstimatesBCO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BCO. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 60.86, the valuation of BCO can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BCO indicates a slightly more expensive valuation: BCO is more expensive than 78.26% of the companies listed in the same industry.
BCO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.94.
Industry RankSector Rank
PE N/A
Fwd PE 60.86
BCO.DE Price Earnings VS Forward Price EarningsBCO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCO.DE Per share dataBCO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BCO's earnings are expected to grow with 32.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.72%
EPS Next 3Y32.64%

More info and screens

0

5. Dividend

5.1 Amount

BCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

FRA:BCO (8/20/2025, 5:29:35 PM)

193.32

-1.34 (-0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-21 2025-10-21/bmo
Inst Owners74.41%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap146.18B
Analysts83.78
Price Target223.62 (15.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.93%
Min EPS beat(2)18.67%
Max EPS beat(2)63.2%
EPS beat(4)3
Avg EPS beat(4)-1.39%
Min EPS beat(4)-91.07%
Max EPS beat(4)63.2%
EPS beat(8)5
Avg EPS beat(8)3%
EPS beat(12)6
Avg EPS beat(12)-778.57%
EPS beat(16)6
Avg EPS beat(16)-766.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)1.11%
Revenue beat(4)1
Avg Revenue beat(4)-3.27%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)1.11%
Revenue beat(8)2
Avg Revenue beat(8)-2.51%
Revenue beat(12)3
Avg Revenue beat(12)-2.89%
Revenue beat(16)3
Avg Revenue beat(16)-5.01%
PT rev (1m)11.62%
PT rev (3m)25.5%
EPS NQ rev (1m)-29.71%
EPS NQ rev (3m)-301.37%
EPS NY rev (1m)0%
EPS NY rev (3m)3.38%
Revenue NQ rev (1m)1.14%
Revenue NQ rev (3m)0.28%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)2.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 60.86
P/S 2.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-15.47
EYN/A
EPS(NY)3.18
Fwd EY1.64%
FCF(TTM)-9.67
FCFYN/A
OCF(TTM)-7
OCFYN/A
SpS85.27
BVpS-3.73
TBVpS-13.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 125.6%
Cap/Sales 3.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.38
Altman-Z 1.25
F-Score3
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-132.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.24%
EPS Next Y91.1%
EPS Next 2Y47.72%
EPS Next 3Y32.64%
EPS Next 5Y21.08%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%34.88%
Revenue Next Year26.24%
Revenue Next 2Y20.59%
Revenue Next 3Y17.28%
Revenue Next 5Y14.49%
EBIT growth 1Y-418.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.59%
EBIT Next 3Y49.36%
EBIT Next 5Y32.37%
FCF growth 1Y-209.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-167.19%
OCF growth 3YN/A
OCF growth 5YN/A